Medical Specialties > Interventional Cardiology > Platinum Stent  > Long Lesions

Designed for complex PCI
Excellent conformability to vessel anatomy and Largest on-label overexpansion limits to accomodate proximal to distal tapered vessels

The First & Only 48mm DES in the U.S.
Excellent Conformability

Excellent Conformability

Helps minimize vessel straightening, which is associated with improved blood flow within the vessel, contributing to low event rates.1

Learn more
Excellent Conformability
Exceptional Overexpansion up to 5.75 mm*

Exceptional Overexpansion

Expands up to 5.75 mm† to enable natural vessel tapering.

Learn more
Exceptional Overexpansion up to 5.75 mm*
Kang Network Meta-Analysis

Quality Outcomes for Patients

EVOLVE 48 Clinical Trial 1-year results with the SYNERGY™ 48 mm Stent§:

- 100 patients across 15 sites in U.S., Europe and New Zealand
- 100% B2/C lesions
- 27% diabetes mellitus

Learn more
Quality Outcomes for Patients
 
 

Ordering Information

Ordering Information

SYNERGY™ Stent, now available in 4.5 mm and 5.0 mm

Stent Length (mm)
ø 
(mm)		81216202428323848Over
Expansion
Capability
2.25H7493926208220H7493926212220H7493926216220H7493926220220H7493926224220H7493926228220H7493926232220H7493926238220 3.50
2.50H7493926208250H7493926212250H7493926216250H7493926220250H7493926224250H7493926228250H7493926232250H7493926238250H74939262482503.50
2.75H7493926208270H7493926212270H7493926216270H7493926220270H7493926224270H7493926228270H7493926232270H7493926238270H74939262482703.50
3.00H7493926208300H7493926212300H7493926216300H7493926220300H7493926224300H7493926228300H7493926232300H7493926238300H74939262483004.25
3.50H7493926208350H7493926212350H7493926216350H7493926220350H7493926224350H7493926228350H7493926232350H7493926238350H74939262483504.25
4.00H7493926208400H7493926212400H7493926216400H7493926220400H7493926224400H7493926228400H7493926232400H7493926238400H74939262484005.75
 4.50 H7493926212450H7493926216450H7493926220450
H7493926224450H7493926228450H7493926232450  5.75
5.00 H7493926212500H7493926216500H7493926220500H7493926224500H7493926228500H7493926232500  5.75
 
 

Continued Research

Addressing the Full Spectrum of Cardiovascular Disease Complexity

Continued Research
Continued Research
Top